Diabetic Macular Edema
📧 Sign up to get email alerts when something new happens for Diabetic Macular Edema.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema [Phase 4]
Phase 4 trial comparing ranibizumab to bevacizumab on macular perfusion in diabetic macular edema was terminated.
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: Comparison of Treatments in Diabetic Macular Edema [Phase 4]
Phase 4 clinical trial comparing treatments for Diabetic Macular Edema has been completed.
-
FDA approval · 2023-01-27FDA Approved: VABYSMO — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for VABYSMO (faricimab) from Genentech, Inc., regarding an updated indication or labeling. This …
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME [Phase 4]
Phase 4 trial evaluating intravitreal ranibizumab with or without micropulse laser for diabetic macular edema has completed.
-
FDA approval · 2022-12-19FDA Approved: OZURDEX — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for OZURDEX (dexamethasone intravitreal implant) from Allergan, Inc., resulting in labeling chan…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-09Clinical Trial Update: Intravitreal Faricimab in Diabetic Macular Edema With Limited Response to Aflibercept [Phase 4]
Phase 4 clinical trial update evaluating intravitreal faricimab in patients with diabetic macular edema who show limited response to afliber…
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema [Phase 3]
Phase 3 trial comparing brolucizumab to aflibercept in diabetic macular edema has completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-24Clinical Trial Update: Analysis of Cytokines in Response to Treatment of Diabetic Macular Edema With 0.3mg Lucentis [Phase 4]
Phase 4 trial analyzing cytokine response to 0.3mg Lucentis in diabetic macular edema has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-17Clinical Trial Update: Additional Effect of Subthreshold Micropulse Laser to Intravitreous Injection of Bevacizumab on Diabetic Macular Edema [Phase 2, Phase 3]
A clinical trial investigating the additional effect of subthreshold micropulse laser combined with intravitreal bevacizumab for diabetic ma…
-
CLINICAL_TRIALS trial_result · 2022-10-10Clinical Trial Update: A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug) in the Treatment of Diabetic Macular Edema. [Phase 2]
Phase 2 trial evaluating oral danazol for diabetic macular edema completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never Treated [Phase 4]
A Phase 4 clinical trial updating the effectiveness and safety of OZURDEX in patients with diabetic macular edema who have not been treated …
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: Extension Study of MYL-1701P-3001 for Safety and Efficacy [Phase 3]
Extension study results for MYL-1701P-3001 in diabetic macular edema evaluating safety and efficacy after Phase 3.
-
FDA approval · 2022-08-15FDA Approved: BYOOVIZ — Supplemental Application (BIOGEN INC.)
FDA approves Biogen's BYOOVIZ (ranibizumab-nuna) via a supplemental application, authorizing the biosimilar for the same ocular indications …
-
FDA approval · 2022-08-02FDA Approved: CIMERLI — Original Application (Coherus BioSciences Inc)
FDA approved CIMERLI (ranibizumab-eqrn) from Coherus as an original Biologics License Application. It is a biosimilar to ranibizumab (Lucent…
-
CLINICAL_TRIALS withdrawal · 2022-08-02Clinical Trial Update: Non-Responsive Diabetic Macular Edema and Spironolactone [Phase 4]
A Phase 4 clinical trial investigating spironolactone for non-responsive diabetic macular edema has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-06-22Clinical Trial Update: A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema [Phase 1, Phase 2]
A dose-ranging study of OPT-302 in combination with aflibercept for persistent diabetic macular edema has completed (Phase 1/Phase 2) with r…
-
CLINICAL_TRIALS trial_result · 2022-06-10Clinical Trial Update: A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular Edema [NA]
Pilot study evaluating photobiomodulation therapy for diabetic macular edema has completed with results posted.
-
FDA approval · 2022-06-09FDA Approved: BYOOVIZ — Supplemental Application (BIOGEN INC.)
The FDA approved a supplemental application for BYOOVIZ (ranibizumab-nuna) from Biogen, authorizing its use as a biosimilar to ranibizumab.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Efficacy and Safety of Dexamethasone Nanoparticles Eye Drops in Diabetic Macular Edema [Phase 2]
Phase 2 clinical trial assessing efficacy and safety of dexamethasone nanoparticle eye drops for diabetic macular edema has completed with p…
-
CLINICAL_TRIALS trial_result · 2022-05-26Clinical Trial Update: Bevacizumabe or Triamcinolone for Persistent Diabetic Macular Edema [Phase 2, Phase 3]
Clinical trial update on bevacizumab or triamcinolone for persistent diabetic macular edema (Phase 2/Phase 3) completed.
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN) [Phase 3]
Phase 3 trial of a novel ocular antiseptic for diabetic macular edema and branch retinal vein occlusion was terminated.
-
CLINICAL_TRIALS trial_result · 2022-04-21Clinical Trial Update: Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema [Phase 3]
Phase 3 trial comparing brolucizumab to aflibercept in diabetic macular edema completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: SD-OCT Angiography [NA]
Clinical trial update for SD-OCT Angiography study (NCT02510885) sponsored by Duke University; the trial is terminated, with results posted …
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: Efficacy and Safety of 9MW0813 in Subjects With Diabetic Macular Edema [Phase 3]
Phase 3 trial update on 9MW0813 for diabetic macular edema focusing on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE) [Phase 3]
This trial result update reports the efficacy and safety outcomes from Roche's YOSEMITE Phase 3 study of Faricimab in diabetic macular edema…